Abstract
Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.
Keywords: Cancer, dendritic cells, immunotherapy, neoplasia, new aspects, patents in immunotherapy, tumor.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Dendritic Cell Vaccine and Cancer Treatment: New Patents
Volume: 8 Issue: 1
Author(s): Andre A.R. Aleixo, Marcia A. Michelin and Eddie F.C. Murta
Affiliation:
Keywords: Cancer, dendritic cells, immunotherapy, neoplasia, new aspects, patents in immunotherapy, tumor.
Abstract: Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.
Export Options
About this article
Cite this article as:
Aleixo A.R. Andre, Michelin A. Marcia and Murta F.C. Eddie, Dendritic Cell Vaccine and Cancer Treatment: New Patents, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2014; 8 (1) . https://dx.doi.org/10.2174/1872214807666140107152008
DOI https://dx.doi.org/10.2174/1872214807666140107152008 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry Molecular Design, Synthesis and Evaluation of 2,3-Diarylquinoxalines as Estrogen Receptor Ligands
Medicinal Chemistry Subcellular Detection and Localization of the Drug Transporter P-Glycoprotein in Cultured Tumor Cells
Current Protein & Peptide Science Proteolytic Cleavage of Notch: “HIT and RUN”
Current Molecular Medicine Adipobiology of Disease: Adipokines and Adipokine-Targeted Pharmacology
Current Pharmaceutical Design Insights into the Platelet Releasate
Current Pharmaceutical Design The Role of PARP Inhibitors in the Treatment of Ovarian Carcinomas
Current Pharmaceutical Design Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Current Topics in Medicinal Chemistry Dexmedetomidine: A Novel Anesthetic Agent for Middle Ear Surgery
Recent Patents on CNS Drug Discovery (Discontinued) Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors
Current Medicinal Chemistry Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment
Clinical Cancer Drugs Pattern of Medication Use Among Older Inpatients in Seven Hospitals in Italy: Results from the Criteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) Project
Current Drug Safety FDG-PET Imaging in Large Vessel Vasculitis and Polymyalgia Rheumatica: A Personal View
Current Immunology Reviews (Discontinued) Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Current Signal Transduction Therapy Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics
Current Drug Targets Targeting Breast Cancer Stem Cells (BCSCs) with Liposomal Formulations
Clinical Cancer Drugs Advances in Photodynamic Therapy of Cancer
Current Cancer Therapy Reviews From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology